Identification of potent agonists of photoreceptor-specific nuclear receptor (NR2E3) and preparation of a radioligand
- Bioorg Med Chem Lett. 2006 Oct 1;16(19):5001-4. doi: 10.1016/j.bmcl.2006.07.056.
Affiliations
- 1. Department of Medicinal Chemistry, Technology Enabled Synthesis Group, Merck & Co., Inc., PO Box 4, West Point, PA 19486, USA. [email protected]
PMID: 16879962
DOI: 10.1016/j.bmcl.2006.07.056
Abstract
Agonists of NR2E3 (PNR, RNR) have been identified and optimized to EC(50)< 200 nM. A tritiated analogue of one agonist was prepared to aid in the development of a binding assay.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Orphan Nuclear ReceptorResearch Areas: Inflammation/Immunology